A Safety Study of SGN-CD33A in AML Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01902329 |
Recruitment Status :
Completed
First Posted : July 18, 2013
Last Update Posted : January 5, 2018
|
Sponsor:
Seagen Inc.
Information provided by (Responsible Party):
Seagen Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | March 18, 2016 |
Actual Study Completion Date : | December 8, 2017 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):